CoreCap Advisors’s Zivo Bioscience ZIVO Stock Holding History
Bought
Maintained
Sold
CoreCap Advisors's ZIVO Position: Q3 2026 in Review
CoreCap Advisors held its Zivo Bioscience (ZIVO) position steady in Q3 2026 at 4,360 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1974.
CoreCap Advisors first reported a position in ZIVO in Q2 2025 and has held it in 6 quarters since. The position peaked at $58.9K in Q2 2025. 1 fund tracked by Wall St. Rank holds ZIVO as of Q3 2026.
- CoreCap Advisors held 4,360 shares of Zivo Bioscience worth $13.2K as of Q3 2026.
- CoreCap Advisors left its Zivo Bioscience share count unchanged in Q3 2026.
- Zivo Bioscience made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1974 holding.
- CoreCap Advisors first reported a position in Zivo Bioscience in Q2 2025 and has held it in 6 quarters since.
- CoreCap Advisors's Zivo Bioscience position peaked at $58.9K in Q2 2025.
- 1 fund tracked by Wall St. Rank held Zivo Bioscience as of Q3 2026.
Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.